| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Laurus Labs Limited (NSE: LAURUSLABS)
LAURUSLABS Technical Analysis
4
| As on 17th May 2024 LAURUSLABS SHARE Price closed @ 440.15 and we RECOMMEND Strong Buy for LONG-TERM with Stoploss of 393.65 & Buy for SHORT-TERM with Stoploss of 422.58 we also expect STOCK to react on Following IMPORTANT LEVELS. |
LAURUSLABSSHARE Price
| Open | 445.10 | Change | Price | % |
| High | 448.00 | 1 Day | -2.60 | -0.59 |
| Low | 438.00 | 1 Week | 2.60 | 0.59 |
| Close | 440.15 | 1 Month | -3.00 | -0.68 |
| Volume | 480593 | 1 Year | 128.30 | 41.14 |
| 52 Week High 611.05 | 52 Week Low 289.75 | ||||
| LAURUSLABS CURRENT MONTH FUTURE | |||
| Close | 441.70 | ||
| Contracts Traded | 2223600 | ||
| Open Intrest | 12245100 | ||
| Change In O.I | -2.49 % | ||
| Lot Size | 1700 | ||
| LAURUSLABS CURRENT MONTH OPTION | |
| Most Active Call | 450.00 |
| Most Active put | 440.00 |
| Highest O.I Buildup Call | 460.00 |
| Highest O.I Buildup Put | 400.00 |
| Expiry Date | 2024-05-30 |
| LAURUSLABS ALL MONTHS OPTIONS | |||
| For All LAURUSLABS Options Click Here | |||
NSE INDIA Most Active Stocks
| IDEA | 13.25 | 0.76% |
| IRFC | 169.00 | 7.20% |
| YESBANK | 23.00 | 1.55% |
| BEL | 248.20 | 4.33% |
| NHPC | 99.25 | 1.07% |
| IFCI | 61.45 | 9.93% |
| RTNPOWER | 13.20 | 4.76% |
| CROMPTON | 391.90 | 15.57% |
| GTLINFRA | 1.55 | 0.00% |
| CANBK | 113.80 | 0.09% |
NSE INDIA Top Gainers Stocks
NSE INDIA Top Losers Stocks
| VARDMNPOLY | 11.60 | -89.50% |
| MRO-TEK | 101.40 | -9.95% |
| SANGHVIMOV | 1176.85 | -8.07% |
| GRPLTD | 7302.55 | -7.83% |
| GODHA | 0.65 | -7.14% |
| NAVA | 499.60 | -6.01% |
| STEELCITY | 98.35 | -5.57% |
| ECLERX | 2278.80 | -5.13% |
| HONAUT | 52912.00 | -5.07% |
| MASKINVEST | 87.55 | -4.99% |
| LAURUSLABS Daily Charts |
LAURUSLABS Intraday Charts |
Whats New @ Bazaartrend |
LAURUSLABS Free Analysis |
|
|
LAURUSLABS Important Levels Intraday
| RESISTANCE | 459.42 |
| RESISTANCE | 453.24 |
| RESISTANCE | 449.42 |
| RESISTANCE | 445.60 |
| SUPPORT | 434.70 |
| SUPPORT | 430.88 |
| SUPPORT | 427.06 |
| SUPPORT | 420.88 |
LAURUSLABS Target May 2024
| 4th UP Target | 506.9 |
| 3rd UP Target | 474.3 |
| 2nd UP Target | 454.15 |
| 1st UP Target | 434 |
| 1st DOWN Target | 376.5 |
| 2nd DOWN Target | 356.35 |
| 3rd DOWN Target | 336.2 |
| 4th DOWN Target | 303.6 |
LAURUSLABS Weekly Target
| 4th UP Target | 501.14 |
| 3rd UP Target | 480.75 |
| 2nd UP Target | 468.14 |
| 1st UP Target | 455.54 |
| 1st DOWN Target | 419.57 |
| 2nd DOWN Target | 406.96 |
| 3rd DOWN Target | 394.35 |
| 4th DOWN Target | 373.96 |
LAURUSLABS Target2024
| 4th UP Target | 1059.65 |
| 3rd UP Target | 857.78 |
| 2nd UP Target | 733 |
| 1st UP Target | 608.22 |
| 1st DOWN Target | 252.18 |
| 2nd DOWN Target | 127.4 |
| 3rd DOWN Target | 2.62 |
| 4th DOWN Target | -199.25 |
Laurus Labs Limited ( NSE INDIA Symbol : LAURUSLABS )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
LAURUSLABS Synopsis Technicals View
| 50 Day EMA |
Close is Above EMA 50 (Short Term) |
Bullish | |
| 100 Day EMA | Close is Above EMA 100 (Mid Term) | Bullish | |
| 200 Day EMA | Close is Above EMA 200 (Long Term) | Bullish | |
| MACD (12 26 9) | MACD Line is Less Then SIGNAL Line | Bearish | |
| RSI (14) | RSI is Below 30 | Over Sold | |
| MFI (14) | MFI is 50.12 | Sideways | |
| CCI (20) | CCI is Below -100 | Over Sold | |
| WILLIAM %R (14) | William %R is -62.71 | Sideways | |
| ADX (14) | ADX is Above 20 & +DI is Below -DI | Down Trend | |
| PSAR | Stoploss For Long Buy | 420.00 | |
| 10 Day Avg Volume | Traded -23.18 % Less then 10 Day Average Volume | ||
LAURUSLABS Other Details
| Segment | EQ | |
| Market Capital | 308174585856.00 | |
| Sector | Healthcare | |
| Industry | Drug Manufacturers-Specialty & Generic | |
| Offical website | > | |
LAURUSLABS Address
 |
||
LAURUSLABS Latest News
LAURUSLABS Business Profile
Laurus Labs Limited, together with its subsidiaries, engages in the development, manufacture, and sale of medicines and active pharmaceutical ingredients (APIs) in India and internationally. The company develops, manufactures, and sells APIs and advanced intermediates for anti-retroviral (ARV), antidiabetic, cardiovascular, proton pump inhibitors (PPIs), oncology, gastroenterology, and hepatitis C therapeutic areas. It also develops and manufactures oral solid formulations for ARVs, anti-diabetic, cardiovascular, PPIs, and central nervous system. In addition, the company provides contract development and manufacturing services for pharmaceutical companies; and manufactures and sells specialty ingredients used in the nutraceutical, dietary supplements, and cosmeceutical products. Further, it offers chemistry, IP development, business support, and related services to the pharmaceutical community. Laurus Labs has agreements with Unitaid and the Clinton Health Access Initiative, Inc. to enhance the development, commercialization, and registration of second- and third-line HIV treatment darunavir boosted with ritonavir for children. The company was incorporated in 2005 and is based in Hyderabad, India. Address: Serene Chambers, Hyderabad, India, 500034
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service